NUWE
Get informed when a big investor buys or sells
+ FollowOvervalued by 201% based on the discounted cash flow analysis.
| Market cap | $698,392.00 |
|---|---|
| Enterprise Value | $-1,119,608.00 |
| Dividend Yield | $- (-) |
| Earnings per Share | $-25.39 |
| Beta | 0.25 |
| Outstanding Shares | 2,074,940 |
| P/E Ratio | -0.09 |
|---|---|
| PEG | -0.19 |
| Price to Sales | 0.12 |
| Price to Book Ratio | 0.49 |
| Enterprise Value to Revenue | -0.13 |
| Enterprise Value to EBIT | 0.13 |
| Enterprise Value to Net Income | 0 |
| Total Debt to Enterprise | -0.24 |
| Debt to Equity | 0.09 |
No data
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | - |
| Total Puts | - |
Holdings and activity of institutional investors.
| Ownership % | 14.02%▲ 5.93% |
|---|---|
| Total Invested | $305,343▲ 34.42% |
| Investors Holding | 8▼ 2.00% |
No data
Nuwellis, Inc. , formally CHF Solutions, is a medical device company dedicated to changing the lives of patients suffering from fluid overload through science, collaboration, and innovation. The Company is focused on developing, manufact...